A co-leader of the firm’s global life sciences industry team, Olga Berson combines two decades of experience in transactional and litigation patent matters with advanced science and engineering training to bring her clients creative and practical patent strategies that align with their business objectives, maximize patent portfolio value, and win in courtrooms. Olga represents clients in diverse technical areas, including the formulation and manufacturing of biopharmaceuticals (small and large molecules), drug delivery platforms, medical devices, analytical methods and equipment, skin care and cosmetics, foods and nutraceuticals, commodity and specialty chemicals and materials.
Olga advises multinational and emerging companies, research institutions, startups, venture capital firms, and individual investors on intellectual property issues that arise in due diligence investigations, including in connection with mergers, acquisitions, divestitures, recapitalizations, and bankruptcies. She counsels clients on patentability of inventions, freedom to operate strategies, third-party patent landscape analyses, and patent validity issues. Olga also advises biopharmaceutical clients on the interplay between regulatory (FDA) and patent issues both in product life cycle management and in litigation.
Olga’s diverse practice includes Hatch-Waxman and biologics patent litigation, Biologics Price Competition and Innovation Act (BPCIA) proceedings and litigation, and US Patent and Trademark Office proceedings. She represents clients in patent disputes before various federal district and appellate courts, including the US Court of Appeals for the Federal Circuit, arbitration panels, the International Trade Commission, and the US Patent and Trademark Office.
Olga holds a Ph.D. in environmental science (bioremediation and microbiology) and chemistry from California Institute of Technology (Caltech). Her undergraduate degree is in chemical and environmental engineering. With this broad technical foundation, she quickly develops a sophisticated understanding of her clients’ technologies, works effectively with inventors and scientific experts, and distills complex technical issues into compelling legal arguments.
Patent Due Diligence Investigations
Strategic Patent Portfolio Development and Counseling
Patent Litigation and Post-Grant Proceedings
Life Sciences Star, Intellectual Property, LMG Life Sciences (2022)
Member, Practice Group of the Year, Intellectual Property, Law360 (2019)
Member, Litigation Department of the Year–Intellectual Property, The American Lawyer (2019)
Member, American Bar Association
Member, American Chemical Society
Rising Star for Intellectual Property, Super Lawyers (2005, 2008)
Rising Star for Intellectual Property Litigation, Super Lawyers (2005, 2008)